Multifunctional Theranostic Nanomedicines in Cancer 2021
DOI: 10.1016/b978-0-12-821712-2.00007-4
|View full text |Cite
|
Sign up to set email alerts
|

Blood–brain-barrier crossing nanotheranostics in brain cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 113 publications
1
1
0
Order By: Relevance
“…The presence of dye in the formulation resulted in a slower drug release rate, which could be attributed to the complex drug-dye interaction. 1 Similar have been reported in the literature, where the presence of an additive in the formulation reduced the rate of drug release. 59,60 The diffusion coefficients were calculated using eqn (1) and ( 2).…”
Section: Biomaterials Science Papersupporting
confidence: 80%
See 1 more Smart Citation
“…The presence of dye in the formulation resulted in a slower drug release rate, which could be attributed to the complex drug-dye interaction. 1 Similar have been reported in the literature, where the presence of an additive in the formulation reduced the rate of drug release. 59,60 The diffusion coefficients were calculated using eqn (1) and ( 2).…”
Section: Biomaterials Science Papersupporting
confidence: 80%
“…Central Nervous System disorders, including Alzheimer's disease, Parkinson's disease, and Ischemic stroke, are increasingly prevalent worldwide. 1,2 While several drugs have been created to treat and manage these neurological disorders, drug delivery to the targeted site remains a significant obstacle. 3 To address drug delivery challenges and enhance medication's therapeutic effectiveness, various drug delivery systems such as polymeric microparticles, nanoparticles, and self-micro and nano-emulsifying drug delivery systems (SMEDD/SNEDD) have been developed.…”
Section: Introductionmentioning
confidence: 99%